ArticleEuropean journal of pediatrics2025
Early and rapid prediction of severe Human Bocavirus 1 pneumonia in children: an age-stratified Nomogram Model based on admission data.
Article in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
This study aims to identify independent risk factors for severe Human Bocavirus 1(HBoV1) pneumonia in children across different age groups and to develop reliable age-stratified nomogram models based on early admission data for the rapid prediction of disease progression and severity. A total of 370 children with HBoV1 pneumonia hospitalized at Tianjin Children's Hospital from September 2022 to August 2024 were retrospectively analyzed. Patients were divided into three age groups for analysis: Group 1 (< 24 months), Group 2 (24-47 months), and Group 3 (≥ 48 months). Multivariate logistic regression was used to identify independent risk factors. Of 370 HBoV1 pneumonia cases, severe pneumonia occurred in 145 (39.2%), with the highest incidence in Group 3 (50.6%, 42/83) versus 37.7% (43/114) and 34.7% (60/173) in other groups. For Group 1, the prediction model included BMI, maximum temperature before admission, pleural thickening, CK, CKMB, and IL-6. For Group 2, the key predictors were history of eczema, pleural thickening, and N%. For Group 3, the model incorporated L%, ALB, CK, C3, and Absolute CD3 Cell Count. The areas under the ROC curve for the three age-specific models were 0.819 (95% CI: 0.7405-0.8978), 0.729 (95% CI: 0.652-0.8064), and 0.801 (95% CI: 0.7064-0.8952), respectively. The decision curve analysis curve demonstrated outstanding net benefit. The C-index values in each group were respectively 0.791, 0.727, and 0.768.
conclusionThis study develops age-stratified prediction models for severe human bocavirus 1 pneumonia in children based on early admission data. Nomograms for all three age groups exhibited good calibration performance and demonstrated clinical applicability. WHAT IS KNOWN: • Human Bocavirus 1 (HBoV1) is a significant respiratory pathogen in children, capable of causing pneumonia with varying severity, from mild to life-threatening. • Age is a key predictor of severe pneumonia in children. WHAT IS NEW: • The clinical manifestations and laboratory findings in children with Human Bocavirus 1 pneumonia exhibit age-specific characteristics. • Based on early admission data, this study developed age-stratified prediction models for severe Human Bocavirus 1 pneumonia in children, which demonstrated good performance.
Indexed as
Identifiers
41315120What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.